[go: up one dir, main page]

GB201710906D0 - Compounds and methods for treating peripheral neuropathy - Google Patents

Compounds and methods for treating peripheral neuropathy

Info

Publication number
GB201710906D0
GB201710906D0 GBGB1710906.7A GB201710906A GB201710906D0 GB 201710906 D0 GB201710906 D0 GB 201710906D0 GB 201710906 A GB201710906 A GB 201710906A GB 201710906 D0 GB201710906 D0 GB 201710906D0
Authority
GB
United Kingdom
Prior art keywords
compounds
methods
peripheral neuropathy
treating peripheral
treating
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1710906.7A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vicore Pharma AB
Original Assignee
Vicore Pharma AB
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vicore Pharma AB filed Critical Vicore Pharma AB
Priority to GBGB1710906.7A priority Critical patent/GB201710906D0/en
Publication of GB201710906D0 publication Critical patent/GB201710906D0/en
Priority to PCT/GB2018/051934 priority patent/WO2019008393A1/en
Ceased legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
GBGB1710906.7A 2017-07-06 2017-07-06 Compounds and methods for treating peripheral neuropathy Ceased GB201710906D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GBGB1710906.7A GB201710906D0 (en) 2017-07-06 2017-07-06 Compounds and methods for treating peripheral neuropathy
PCT/GB2018/051934 WO2019008393A1 (en) 2017-07-06 2018-07-06 Compounds and methods for treating peripheral neuropathy

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1710906.7A GB201710906D0 (en) 2017-07-06 2017-07-06 Compounds and methods for treating peripheral neuropathy

Publications (1)

Publication Number Publication Date
GB201710906D0 true GB201710906D0 (en) 2017-08-23

Family

ID=59676599

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1710906.7A Ceased GB201710906D0 (en) 2017-07-06 2017-07-06 Compounds and methods for treating peripheral neuropathy

Country Status (2)

Country Link
GB (1) GB201710906D0 (en)
WO (1) WO2019008393A1 (en)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB201913603D0 (en) 2019-09-20 2019-11-06 Vicore Pharma Ab New compounds
GB201917327D0 (en) 2019-11-28 2020-01-15 Vicore Pharma Ab New pharmaceutical use
IL296247A (en) 2020-03-19 2022-11-01 Vicore Pharma Ab Novel compounds for use in the treatment and/or prevention of an angiotensin ii-related disease, disorder or condition
GB202004094D0 (en) 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
GB202006079D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202006074D0 (en) 2020-04-24 2020-06-10 Vicore Pharma Ab New composition
GB202013721D0 (en) 2020-09-01 2020-10-14 Vicore Pharma Ab New compounds
GB202104033D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
GB202104038D0 (en) 2021-03-23 2021-05-05 Vicore Pharma Ab New compounds
JP2024511453A (en) 2021-03-23 2024-03-13 ヴィコール ファルマ アーベー Selective angiotensin II receptor ligand
US20240262813A1 (en) 2021-07-09 2024-08-08 Vicore Pharma Ab New selective angiotensin ii compounds
WO2024149712A1 (en) 2023-01-09 2024-07-18 Vicore Pharma Ab Selective angiotensin ii compounds

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1395566T3 (en) * 2001-05-31 2008-01-07 Vicore Pharma Ab Tricyclic compounds useful as angiotensin II agonists
ES2425567T3 (en) * 2004-12-24 2013-10-16 Spinifex Pharmaceuticals Pty Ltd Method of treatment or prophylaxis
WO2014021942A1 (en) * 2012-08-01 2014-02-06 University Of Southern California Methods for limiting development of neurodegeneration

Also Published As

Publication number Publication date
WO2019008393A1 (en) 2019-01-10

Similar Documents

Publication Publication Date Title
GB201710906D0 (en) Compounds and methods for treating peripheral neuropathy
IL262225A (en) Methods for monitoring and treating cancer
IL289423A (en) Compounds and methods for treating neurological and cardiovascular conditions
IL262223A (en) Methods for monitoring and treating cancer
PT3490582T (en) Methods and compositions for treating myelofibrosis
IL251215A0 (en) Cannabinoid composition and method for treating pain
HK1244217A1 (en) Methods for treating proteinopathies
IL262825A (en) Tetrahydropyrimidodiazepine and tetrahydropyridodiazepine compounds for treating pain and pain related conditions
EP3634369C0 (en) Methods for treating chemically relaxed hair
GB2567616B (en) Treatment method
EP3589659A4 (en) Compounds and methods for treating cancer
GB2571601B (en) Treatment method
ZA201906047B (en) Compounds for treating tuberculosis
SG11202001806TA (en) Treatment method
ZA202000407B (en) Device and method for treating must
EP3303289A4 (en) Compounds and methods for treating cancer
IL270867A (en) Treatment method
IL271967A (en) Methods for treating congenital hyperinsulinism
SG11202005278PA (en) Compounds for treating eye diseases and methods thereof
GB201609402D0 (en) Materials and methods for treating cancer
IL281343A (en) Methods for treating pancreatitis
GB201706821D0 (en) Compounds and methods for treating obesity
GB201720089D0 (en) Means and methods for treating cancer
GB201720943D0 (en) New processes and compounds
GB201719043D0 (en) Methods and compounds

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)